Published in J Neurol Sci on August 15, 2002
Role of microglia in neurotrauma. Neurotherapeutics (2010) 2.53
Microglia activation as a biomarker for traumatic brain injury. Front Neurol (2013) 1.23
Antiinflammatory activity of melatonin in central nervous system. Curr Neuropharmacol (2010) 1.09
Postinjury estrogen treatment of chronic spinal cord injury improves locomotor function in rats. J Neurosci Res (2010) 1.06
MicroRNA dysregulation in the spinal cord following traumatic injury. PLoS One (2012) 0.98
MicroRNA dysregulation in spinal cord injury: causes, consequences and therapeutics. Front Cell Neurosci (2014) 0.91
Traumatic brain injury, microglia, and Beta amyloid. Int J Alzheimers Dis (2012) 0.90
Inhibition of calpain attenuates encephalitogenicity of MBP-specific T cells. J Neurochem (2009) 0.90
Brain injury, neuroinflammation and Alzheimer's disease. Front Aging Neurosci (2013) 0.89
The role of the microglia in acute CNS injury. Metab Brain Dis (2014) 0.88
Enhanced functional recovery in MRL/MpJ mice after spinal cord dorsal hemisection. PLoS One (2012) 0.86
NKCC1 up-regulation contributes to early post-traumatic seizures and increased post-traumatic seizure susceptibility. Brain Struct Funct (2016) 0.81
Evidence for proangiogenic cellular and humoral systemic response in patients with acute onset of spinal cord injury. J Spinal Cord Med (2014) 0.78
Neuroprotection for traumatic brain injury. Handb Clin Neurol (2015) 0.77
Biomaterial Approaches to Enhancing Neurorestoration after Spinal Cord Injury: Strategies for Overcoming Inherent Biological Obstacles. Biomed Res Int (2015) 0.77
Effect of oscillating electrical field stimulation on motor function recovery and myelin regeneration after spinal cord injury in rats. J Phys Ther Sci (2016) 0.76
Identification of temporal genes involved in the mechanisms of spinal cord injury. Spinal Cord (2017) 0.75
Identification of up-regulated genes after complete spinal cord transection in adult rats. Cell Mol Neurobiol (2006) 0.75
MicroRNA-185 regulates spinal cord injuries induced by thoracolumbar spine compression fractures by targeting transforming growth factor-β1. Exp Ther Med (2017) 0.75
Calpain inhibition reduces structural and functional impairment of retinal ganglion cells in experimental optic neuritis. J Neurochem (2016) 0.75
Phase II trial of temozolomide in patients with progressive low-grade glioma. J Clin Oncol (2003) 2.16
Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death. J Neurol Sci (2009) 1.26
Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors. Brain Res Brain Res Rev (2003) 1.22
Molecular evidence of apoptotic death in malignant brain tumors including glioblastoma multiforme: upregulation of calpain and caspase-3. J Neurosci Res (2002) 0.97
Early induction of secondary injury factors causing activation of calpain and mitochondria-mediated neuronal apoptosis following spinal cord injury in rats. J Neurosci Res (2003) 0.90
3-O-acetyl-sphingosine-series myelin glycolipids: characterization of novel 3-O-acetyl-sphingosine galactosylceramide. J Lipid Res (2002) 0.82
T-cells expressing natural killer (NK) receptors are altered in multiple sclerosis and responses to alpha-galactosylceramide are impaired. J Neurol Sci (2008) 0.82
Cerebral amyloidoma mimicking intracranial tumor: a case report. J Med Case Rep (2010) 0.81
Signaling and regulatory functions of bioactive sphingolipids as therapeutic targets in multiple sclerosis. Neurochem Res (2012) 0.81
Absence of Mycoplasma-specific DNA sequence in brain, blood and CSF of patients with multiple sclerosis (MS): a study by PCR and real-time PCR. J Neurol Sci (2007) 0.80
Characterization of novel myelin components 3-O-acetyl-sphingosine galactosylceramides by electrospray ionization Q-TOF MS and MS/CID-MS of Li+ adducts. J Mass Spectrom (2007) 0.80
The structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosis. Clin Lipidol (2011) 0.77
Invariant Natural Killer T-cell anergy to endogenous myelin acetyl-glycolipids in multiple sclerosis. J Neuroimmunol (2013) 0.77
Novel myelin penta- and hexa-acetyl-galactosyl-ceramides: structural characterization and immunoreactivity in cerebrospinal fluid. J Lipid Res (2010) 0.77
5'-flanking region polymorphism of the neuronal nitric oxide synthase gene with Parkinson's disease in Taiwan. J Neurol Sci (2002) 0.76
Cell-specific expression of neutral glycosphingolipids in vertebrate brain: immunochemical localization of 3-O-acetyl-sphingosine-series glycolipid(s) in myelin and oligodendrocytes. J Neurosci Res (2007) 0.76
Sialosyl-galactose: a common denominator of Guillain-Barré and related disorders? J Neurol Sci (2002) 0.76
Markers Distinguishing Cancer Stem Cells from Normal Human Neuronal Stem Cell Populations in Malignant Glioma Patients: 978. Neurosurgery (2009) 0.75